Active, not recruitingPhase 2NCT06004830

Off-Label Medications for Alcohol Use Disorder Among Patients With HIV: Pilot Study 1

Studying Macrocephaly-intellectual disability-neurodevelopmental disorder-small thorax syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Yale University
Principal Investigator
E. Jennifer Edelman, MD, MHS
Yale University
Intervention
Spironolactone(drug)
Enrollment
30 target
Eligibility
18-99 years · All sexes
Timeline
20232027

Study locations (1)

Collaborators

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06004830 on ClinicalTrials.gov

Other trials for Macrocephaly-intellectual disability-neurodevelopmental disorder-small thorax syndrome

Additional recruiting or active studies for the same condition.

See all trials for Macrocephaly-intellectual disability-neurodevelopmental disorder-small thorax syndrome

← Back to all trials